Clinical and laboratory risk factors of thrombotic complications after pacemaker implantation: A prospective study

Europace

Volumn 12, Issue 6, 2010, Pages 817-824

  Korkeila, Petri ^a   Mustonen, Pirjo ^b   Koistinen, Juhani ^a   Nyman, Kai ^a   Ylitalo, Antti ^c   Karjalainen, Pasi ^c   Lund, Juha ^a   Airaksinen, Juhani ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b FINNISH RED CROSS BLOOD SERVICE   (Finland)

^c SATAKUNTA CENTRAL HOSPITAL   (Finland)

Author keywords

Complications; Embolism; Pacemakers; Risk factors; Thrombosis

Indexed keywords

D DIMER; PROTHROMBIN; THROMBOMODULIN; VON WILLEBRAND FACTOR;

AGED; ARTICLE; BLOOD CLOTTING; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PACEMAKER; PHLEBOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SURGICAL TECHNIQUE; THROMBOPHILIA; THROMBOSIS; VASCULAR ACCESS; VENOUS THROMBOEMBOLISM;

AGED; ARRHYTHMIAS, CARDIAC; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PACEMAKER, ARTIFICIAL; PEPTIDE FRAGMENTS; PHLEBOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTHROMBIN; PULMONARY EMBOLISM; RISK FACTORS; THROMBOMODULIN; THROMBOPHILIA; VENOUS THROMBOSIS; VON WILLEBRAND FACTOR;

EID: 77953011912     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq075     Document Type: Article

References (45)

1. Antonelli D, Turgeman Y, Kaveh Z, Artoul S, Rosenfeld T. Short-term thrombosis after transvenous permanent pacemaker insertion. Pacing Clin Electrophysiol 1989; 12:280-282
2. Goto Y, Abe T, Sekine S, Sakurada T. Long-term thrombosis after transvenous permanent pacemaker implantation. Pacing Clin Electrophysiol 1998;21:1192-1195
3. Barakat K, Robinson N, Spurrell R. Transvenous pacing lead-induced thrombosis: a series of cases with a review of the literature. Cardiology 2000;93:142-148
4. Martinez-Sellés M, Bueno H, Almendral J, Diaz-Castro O. Pulmonary embolism after pacemaker implantation. Tex Heart Inst J 2001;28:318-319
5. Sticherling C, Chough S, Baker R, Wasmer K, Oral H, Tada H et al. Prevalence of central venous occlusion in patients with chronic defibrillator leads. Am Heart J 2001;141:813-816
6. Oginosawa Y, Abe H, Nakashima Y. The incidence and risk factors for venous obstruction after implantation of transvenous pacing leads. Pacing Clin Electrophysiol 2002;25:1605-1611
7. Da Costa S, Scalabrini Neto A, Costa R, Caldas J, Martinelli Filho M. Incidence and risk factors of upper extremity deep vein lesions after permanent transvenous pacemaker implant: a 6-month follow-up prospective study. Pacing Clin Electrophysiol 2002;25:1301-1306
8. van Rooden C, Molhoek S, Rosendaal F, Schalij M, Meinders A, Huisman M. Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Cardiovasc Electrophysiol 2004;15:1258-1262
9. Blann A, Lip G. Venous thromboembolism. BMJ 2006;332:215-219
10. Turpie A, Chin B, Lip G. Venous thromboembolism: pathophysiology, clinical features, and prevention. BMJ 2002;325:887-890
11. Anderson FJ, Spencer F. Risk factors for venous thromboembolism. Circulation 2003;107:I9-I16.
12. Karjalainen P, Vikman S, Niemelä M, Porela P, Ylitalo A, Vaittinen M et al. Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment. Eur Heart J 2008;29:1001-1010
13. Annala A, Karjalainen P, Porela P, Nyman K, Ylitalo A, Airaksinen K. Safety of diagnostic coronary angiography during uninterrupted therapeutic warfarin treatment. Am J Cardiol 2008;102:386-390
14. Korkeila P, Nyman K, Ylitalo A, Koistinen J, Karjalainen P, Lund J et al. Venous obstruction after pacemaker implantation. Pacing Clin Electrophysiol 2007;30: 199-206.
15. Korkeila P, Saraste M, Nyman K, Koistinen J, Lund J, Juhani Airaksinen K. Transesophageal echocardiography in the diagnosis of thrombosis associated with permanent transvenous pacemaker electrodes. Pacing Clin Electrophysiol 2006;29: 1245-1250
16. Korkeila P, Ylitalo A, Koistinen J, Airaksinen KEJ. Progression of venous pathology after pacemaker and cardioverter-defibrillator implantation: a prospective serial venographic study. Ann Med 2009;41:216-223
17. Lip G, Blann A. Does hypertension confer a prothrombotic state? Virchow's triad revisited. Circulation 2000;101:218-220
18. Le Gal G, Righini M, Roy P, Meyer G, Aujesky D, Perrier A et al. Differential value of risk factors and clinical signs for diagnosing pulmonary embolism according to age. J Thromb Haemost 2005;3:2457-2464
19. Stein P, Hull R, Kayali F, Ghali W, Alshab A, Olson R. Venous thromboembolism according to age: the impact of an aging population. Arch Intern Med 2004;164: 2260-2265
20. Stein P, Beemath A, Olson R. Obesity as a risk factor in venous thromboembolism. Am J Med 2005;118:978-980
21. Boisclair M, Ireland H, Lane D. Assessment of hypercoagulable states by measurement of activation fragments and peptides. Blood Rev 1990;4:25-40.
22. Lippi G, Franchini M, Targher G, Favaloro E. Help me, Doctor! My D-dimer is raised. Ann Med 2008;40:594-605.
23. Mannucci P. von Willebrand factor: a marker of endothelial damage? Arterioscler Thromb Vasc Biol 1998;18:1359-1362
24. Boehme M, Galle P, Stremmel W. Kinetics of thrombomodulin release and endothelial cell injury by neutrophil-derived proteases and oxygen radicals. Immunology 2002;107:340-349
25. Strijbos M, Rao C, Schmitz P, Kraan J, Lamers C, Sleijfer S et al. Correlation between circulating endothelial cell counts and plasma thrombomodulin levels as markers for endothelial damage. Thromb Haemost 2008;100:642-647
26. Watson T, Shantsila E, Lip G. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet 2009;373:155-166
27. Vaarala O, Vaara M, Palosuo T. Effective inhibition of cardiolipin-binding antibodies in gram-negative infections by bacterial lipopolysaccharide. Scand J Immunol 1988;28:607-612
28. Pauletti M, Pingitore R, Contini C. Superior vena cava stenosis at site of intersection of two pacing electrodes. Br Heart J 1979;42:487-489
29. Van Putte B, Bakker P. Subtotal innominate vein occlusion after unsuccessful pacemaker implantation for resynchronization therapy. Pacing Clin Electrophysiol 2004; 27:1574-1575
30. Bar-Cohen Y, Berul C, Alexander M, Fortescue E, Walsh E, Triedman J et al. Age, size, and lead factors alone do not predict venous obstruction in children and young adults with transvenous lead systems. J Cardiovasc Electrophysiol 2006;17: 754-759
31. Bracke F, Meijer A, Van Gelder L. Symptomatic occlusion of the access vein after pacemaker or ICD lead extraction. Heart 2003;89:1348-1349
32. Ito T, Tanouchi J, Kato J, Nishino M, Iwai K, Tanahashi H et al. Prethrombotic state due to hypercoagulability in patients with permanent transvenous pacemakers. Angiology 1997;48:901-906
33. Lip G, Gibbs C. Does heart failure confer a hypercoagulable state? Virchow's triad revisited. J Am Coll Cardiol 1999;33:1424-1426
34. Davis C, Gurbel P, Gattis W, Fuzaylov S, Nair G, O'Connor C et al. Hemostatic abnormalities in patients with congestive heart failure: diagnostic significance and clinical challenge. Int J Cardiol 2000;75:15-21.
35. Chong A, Lip G. Viewpoint: the prothrombotic state in heart failure: a maladaptive inflammatory response? Eur J Heart Fail 2007;9:124-128
36. Mahé I, Drouet L, Chassany O, Mazoyer E, Simoneau G, Knellwolf A et al. D-dimer: a characteristic of the coagulation state of each patient with chronic atrial fibrillation. Thromb Res 2002;107:1-6.
37. Maŕn F, Roldán V, Climent V, Ibáñez A, Garća A, Marco P et al. Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation. Heart 2004;90:1162-1166
38. Chow B, Hassan A, Chan K, Tang A. Prevalence and significance of lead-related thrombi in patients with implantable cardioverter defibrillators. Am J Cardiol 2003;91:88-90.
39. Haghjoo M, Nikoo M, Fazelifar A, Alizadeh A, Emkanjoo Z, Sadr-Ameli M. Predictors of venous obstruction following pacemaker or implantable cardioverter-defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade. Europace 2007;9:328-332
40. Hakala L, Vahtera E, Krusius T, Rasi V. APC resistance and blood coagulation factor V mutation in Finnish thrombotic patients. Duodecim 1995;111:2143-2151
41. Julkunen H, Jouhikainen T, Kaaja R. Phospholipid antigens, thrombosis and repeated fetal death. Duodecim 1996;112:179-187
42. Kontula K, Ylikorkala A, Miettinen H, Vuorio A, Kauppinen-Mäkelin R, Hämäläinen L et al. Arg506Gln factor V mutation (factor V Leiden) in patients with ischaemic cerebrovascular disease and survivors of myocardial infarction. Thromb Haemost 1995;73:558-560
43. Kuismanen K, Savontaus M, Kozlov A, Vuorio A, Sajantila A. Coagulation factor V Leiden mutation in sudden fatal pulmonary embolism and in a general northern European population sample. Forensic Sci Int 1999;106:71-75
44. Hiltunen L, Rautanen A, Rasi V, Kaaja R, Kere J, Krusius T et al. An unfavorable combination of Factor V Leiden with age, weight, and blood group causes high risk of pregnancy-associated venous thrombosis: a population-based nested casecontrol study. Thromb Res 2007;119:423-432
45. Melzer C, Lembcke A, Ziemer S, Eddicks S, Witte J, Baumann G et al. Pacemakerinduced superior vena cava syndrome: clinical evaluation of long-term follow-up. Pacing Clin Electrophysiol 2006;29:1346-1351